Here are five things to know:
1. Initially, the two will focus on developing products that accelerate and improve individualized treatment options for cancer and critical care patients.
2. Roche and GE hope to develop a digital platform that uses advanced analytics to provide workflow solutions as well as apps to support clinical decisions.
3. The new solutions will enable integration of in-vivo and in-vitro data, patient records, medical best practices, real-time monitoring and research outcomes. Clinicians will also have decision support to provide correct treatment and quality care to patients.
4. GE is a leader in medical imaging equipment, and Roche is global leader in in-vitro diagnostics.
5. “This is the first time that two major players in healthcare have combined advanced analytics with in-vivo and in-vitro diagnostics to this degree,” said Kieran Murphy, GE Healthcare CEO and president. “We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients
and the healthcare industry.”
More articles on imaging:
Prince William scrubs in to observe surgery using da Vinci Surgical System: 4 takeaways
China performs 1st robotic surgery: 5 things to know
The da Vinci Surgical System Xi arrives at Gulf Coast Regional Medical Center: 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
